GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Porton Pharma Solutions Ltd (SZSE:300363) » Definitions » Sale Of Investment

Porton Pharma Solutions (SZSE:300363) Sale Of Investment : ¥281 Mil (TTM As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Porton Pharma Solutions Sale Of Investment?

Porton Pharma Solutions's sale of investment for the three months ended in Mar. 2025 was ¥281 Mil. It means Porton Pharma Solutions gained ¥281 Mil from selling investments. Porton Pharma Solutions's sale of investment for the trailing twelve months (TTM) ended in Mar. 2025 was ¥281 Mil.

Compared with last quarter (¥0 Mil in Dec. 2024 ), Porton Pharma Solutions gained more money from selling investments in Mar. 2025 (¥281 Mil).


Porton Pharma Solutions Sale Of Investment Historical Data

The historical data trend for Porton Pharma Solutions's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Porton Pharma Solutions Sale Of Investment Chart

Porton Pharma Solutions Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.20 90.03 2.79 7.82 -

Porton Pharma Solutions Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 280.94

Porton Pharma Solutions Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥281 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Porton Pharma Solutions Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Porton Pharma Solutions's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Porton Pharma Solutions Business Description

Traded in Other Exchanges
N/A
Address
Fangzheng Avenue, Porton New Drug Outsourcing Service and R&D Center, Shuitu, Beibei District, Chongqing, CHN, 400714
Porton Pharma Solutions Ltd is a China-based external manufacturing supplier of custom drug intermediates and Active Pharmaceutical Ingredients (APIs) to pharmaceutical companies. It is engaged in the process development activities and pilot-scale and commercial-scale manufacturing activities.
Executives
Pi Wei Directors, executives
Chen Hui Executives
Wang Zhong Neng Executives
Yu Yong Mei Executives
Sun Min Executives
Ji Yao Hui Executives
Ju Nian Feng Directors, executives
Tan Jun Supervisors
Xu Ai Wu Directors, executives
Guo Yong Qing Independent director
Director
Director
Ceng Hui Supervisors
Chen Bei Executives

Porton Pharma Solutions Headlines

No Headlines